Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Smith, , Timothy,
DOB: 10-SEP-1941 (Age: 84)
Gender: male
Address:
9 Jeffrey orchard
NW1 North Joshuaville (United Kingdom)
ID: 8029-862360-6 (ECI)
Report
Date: 19-MAY-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 19-MAY-2025

Chemistry

Test 19-MAY-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 131.1 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.6 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 143.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.9 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 26.5 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 244.9 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 490.0 H 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 119.1 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 27.8 L 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 14.7 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Laboratory results show good glycemic control and normal renal function. However, there is significant dyslipidemia with elevated total cholesterol, markedly high triglycerides, and low HDL cholesterol, increasing cardiovascular risk. Electrolytes and other parameters are within normal limits. Lipid management and cardiovascular risk reduction should be considered.